Our Knowledge Publishing

Viral hepatitis B during MIC: Prevalence and therapeutic management

Name: Viral hepatitis B during MIC: Prevalence and therapeutic management
Brand: Our Knowledge Publishing
SKU: e12e1318941d8edd8722be2325daf20b

1/1

Afbeelding van Viral hepatitis B during MIC: Prevalence and therapeutic management

Bol

Prijzen vanaf

48,90

Uitgelicht

	48,90	Naar shop
	48,90	Naar shop
VERGELIJK ALLE AANBIEDERS (2)

Beschrijving

Bol Immunosuppressants (IS) are a cornerstone of the management of inflammatory bowel disease (IBD), thereby increasing the risk of B-virus reactivation (rHVB). The prevalence of HBV infection among patients with IBD is higher than in the general population. Screening for HBV is mandatory in patients with IBD. In cases of IS treatment, HBV requires preemptive or, in some cases, prophylactic treatment depending on serostatus and the risk of reactivation. HBV vaccination is recommended for seronegative individuals.

Lees meer

Vergelijk aanbieders (2)

Sorteren op:

€ 48,90 Gratis verzending

Beschrijving (1)

Immunosuppressants (IS) are a cornerstone of the management of inflammatory bowel disease (IBD), thereby increasing the risk of B-virus reactivation (rHVB). The prevalence of HBV infection among patients with IBD is higher than in the general population. Screening for HBV is mandatory in patients with IBD. In cases of IS treatment, HBV requires preemptive or, in some cases, prophylactic treatment depending on serostatus and the risk of reactivation. HBV vaccination is recommended for seronegative individuals.

Lees meer